AAAAAA

   
Results: 1-24 |
Results: 24
Unrecognized chronic bronchitis
Authors: Leophonte, P Mouton, Y
Citation: P. Leophonte et Y. Mouton, Unrecognized chronic bronchitis, PRESSE MED, 30(31), 2001, pp. 5-5
Review of the 4th Consensus Conference on anti-infectious Therapy of the Societe de Pathologie Infectieuse de Langue Francaise (SPILF). Management ofLower Respiratory Tract Infections
Authors: Mouton, Y Chidiac, C
Citation: Y. Mouton et C. Chidiac, Review of the 4th Consensus Conference on anti-infectious Therapy of the Societe de Pathologie Infectieuse de Langue Francaise (SPILF). Management ofLower Respiratory Tract Infections, MED MAL INF, 31(5), 2001, pp. 267-267
Mycobacterial sepsis following instillation of intravesical Calmette-Guerin bacillus. Is corticosteroidal therapy necessary?
Authors: Legout, L Maulin, L Senneville, E Leduc, L Leroy, O Georges, H Guery, B Beaucaire, G Mouton, Y
Citation: L. Legout et al., Mycobacterial sepsis following instillation of intravesical Calmette-Guerin bacillus. Is corticosteroidal therapy necessary?, MED MAL INF, 31(1), 2001, pp. 29-32
Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts
Authors: Yazdanpanah, Y Chene, G Losino, E Goldie, SJ Merchadou, LD Alfandari, S Seage, GR Sullivan, L Marimoutou, C Paltiel, AD Salamon, R Mouton, Y Freedberg, KA
Citation: Y. Yazdanpanah et al., Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts, INT J EPID, 30(4), 2001, pp. 864-871
Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice
Authors: Bahr, GM Darcissac, ECA Casteran, N Amiel, C Cocude, C Truong, MJ Dewulf, J Capron, A Mouton, Y
Citation: Gm. Bahr et al., Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice, J VIROLOGY, 75(15), 2001, pp. 6941-6952
InHIV-1-infected patients, plasma levels of HIV-1 RNA are inversely correlated with IFN-alpha responsiveness of whole-blood cultures to sendai virus
Authors: Chehadeh, W Chabou, S Fontier, C Alm, G Lion, G Bocket, L Mouton, Y Wattre, P Hober, D
Citation: W. Chehadeh et al., InHIV-1-infected patients, plasma levels of HIV-1 RNA are inversely correlated with IFN-alpha responsiveness of whole-blood cultures to sendai virus, J CLIN VIRO, 16(2), 2000, pp. 123-128
Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients
Authors: Piroth, L Grappin, M Cuzin, L Mouton, Y Bouchard, O Raffi, F Rey, D Peyramond, D Gourdon, F Drobacheff, C Lombart, ML Lucht, F Besnier, JM Bernard, L Chavanet, P Portier, H
Citation: L. Piroth et al., Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients, J VIRAL HEP, 7(4), 2000, pp. 302-308
Nevirapine rash with eosinophilia and hepatitis: DRESS syndrome?
Authors: Sissoko, D Ajana, F de la Tribonniere, X Baclet, V Mouton, Y
Citation: D. Sissoko et al., Nevirapine rash with eosinophilia and hepatitis: DRESS syndrome?, PRESSE MED, 29(19), 2000, pp. 1041-1042
Review of the Fourth Conference on Antifectious Disease Treatment of the Societe de Pathologie Infectieuse de Langue Francaise
Authors: Mouton, Y Chidiac, C
Citation: Y. Mouton et C. Chidiac, Review of the Fourth Conference on Antifectious Disease Treatment of the Societe de Pathologie Infectieuse de Langue Francaise, MED MAL INF, 30(9), 2000, pp. 565-565
Non-pulmonary parameters associated to varicella pneumonia in healthy adults.
Authors: Senneville, E Rivaud, E Valette, M Maulin, L Yasdanpanah, Y Ajana, F Alfandari, S Gerard, Y Behra, JM Caillaux, M Chidiac, C Mouton, Y
Citation: E. Senneville et al., Non-pulmonary parameters associated to varicella pneumonia in healthy adults., MED MAL INF, 30(4), 2000, pp. 211-216
Recommendations of an expert group faced with an influenza pandemic, due to a virus not included in the vaccine
Authors: Mouton, Y
Citation: Y. Mouton, Recommendations of an expert group faced with an influenza pandemic, due to a virus not included in the vaccine, MED MAL INF, 30(2), 2000, pp. 71-79
Ex vivo interferon-gamma response to human immunodefiency virus-1 derived peptides in human immunodeficiency virus-1 infected patients
Authors: Hober, D Benyoucef, S Chehadeh, W De Groote, D De la Tribonniere, X Mouton, Y Wattre, P
Citation: D. Hober et al., Ex vivo interferon-gamma response to human immunodefiency virus-1 derived peptides in human immunodeficiency virus-1 infected patients, SC J IMMUN, 51(4), 2000, pp. 429-433
Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals
Authors: Amiel, C Kusnierz, JP Mouton, Y Rook, G Stanford, J Singh, M Capron, A Bahr, GM
Citation: C. Amiel et al., Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals, J CLIN IMM, 20(6), 2000, pp. 458-465
Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy
Authors: Gerard, Y Maulin, L Yazdanpanah, Y De la Tribonniere, X Amiel, C Maurage, CA Robin, S Sablonniere, B Dhennain, C Mouton, Y
Citation: Y. Gerard et al., Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy, AIDS, 14(17), 2000, pp. 2723-2730
The synthetic immunomodulator Murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells
Authors: Darcissac, ECA Truong, MJ Dewulf, J Mouton, Y Capron, A Bahr, GM
Citation: Eca. Darcissac et al., The synthetic immunomodulator Murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells, J VIROLOGY, 74(17), 2000, pp. 7794-7802
Acquired lower respiratory tract infection
Authors: Huchon, G Chidiac, C Delaval, P Leophonte, P Mouton, Y Roche, N Tremolieres, F
Citation: G. Huchon et al., Acquired lower respiratory tract infection, REV MAL RES, 16(2), 1999, pp. 224-233
Specific immune response to human immunodeficiency virus (HIV)-1 in patients assessed through the production of interferon-gamma and interleukin-4 inHIV-1 p24-activated whole blood cultures: Relationship with the viral loadin plasma
Authors: Hober, D Benyoucef, S Chieux, V De Groote, D De la Tribonniere, X Bocket, L Lion, G Mouton, Y Wattre, P
Citation: D. Hober et al., Specific immune response to human immunodeficiency virus (HIV)-1 in patients assessed through the production of interferon-gamma and interleukin-4 inHIV-1 p24-activated whole blood cultures: Relationship with the viral loadin plasma, SC J IMMUN, 50(1), 1999, pp. 83-90
Biological properties of interferon-alpha produced ex vivo by whole blood of patients infected by human immunodeficiency virus-1
Authors: Chehadeh, W Hober, D Chieux, V Alm, G Harvey, J Lion, G Mouton, Y Wattre, P
Citation: W. Chehadeh et al., Biological properties of interferon-alpha produced ex vivo by whole blood of patients infected by human immunodeficiency virus-1, SC J IMMUN, 49(6), 1999, pp. 660-666
HIV protease inhibitors: drug interactions
Authors: Gerard, Y Maulin, L Dubreuil, L Mouton, Y
Citation: Y. Gerard et al., HIV protease inhibitors: drug interactions, REV MED IN, 20(2), 1999, pp. 141-150
Soluble tumor necrosis factor receptor type II (sTNFRII) in HIV-infected patients: relationship with the plasma level of HIV-1 RNA
Authors: Hober, D Benyoucef, S Bocket, L Chieux, V Lion, G Mouton, Y De Groote, D Wattre, P
Citation: D. Hober et al., Soluble tumor necrosis factor receptor type II (sTNFRII) in HIV-infected patients: relationship with the plasma level of HIV-1 RNA, IMMUNOL LET, 67(2), 1999, pp. 91-94
Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1?
Authors: Yazdanpanah, Y Goldie, SJ Salamon, R Mouton, Y Freedberg, KA
Citation: Y. Yazdanpanah et al., Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1?, LANCET, 354(9186), 1999, pp. 1305-1306
Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression
Authors: Amiel, C Darcissac, E Truong, MJ Dewulf, J Loyens, M Mouton, Y Capron, N Bahr, GM
Citation: C. Amiel et al., Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression, J INFEC DIS, 179(1), 1999, pp. 83-91
Bacterial infections in hospitalized HIV patients
Authors: Alfandari, S Chidiac, C Maulin, L Guery, B Yazdanpanah, Y Gerard, Y Senneville, E Coignard, C de la Tribonniere, X Mouton, Y
Citation: S. Alfandari et al., Bacterial infections in hospitalized HIV patients, MED MAL INF, 28(12), 1998, pp. 956-961
Tacrolimus (FK506) monotherapy provides potent and significant suppressionof allogeneic foetal rat pancreatic allograft rejection
Authors: du Toit, DF Muller, C Mouton, Y Page, B Mattysen, J Lyners, R Woodroof, C
Citation: Df. Du Toit et al., Tacrolimus (FK506) monotherapy provides potent and significant suppressionof allogeneic foetal rat pancreatic allograft rejection, TRANSPLAN P, 30(8), 1998, pp. 4073-4074
Risultati: 1-24 |